Delivery Order SPE2DB22D9205-SPE2DB26FZF67
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $82,920.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90mg/mL syringes. This firm fixed-price delivery order, issued on October 24, 2025, represents one of numerous pharmaceutical supply orders placed with DMS Pharmaceutical Group under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,730.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 130 mg/26 mL vials. The delivery order, issued on October 24, 2025, with an ultimate completion date of November 17, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This award represents one of...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $81,249.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The delivery order, issued on October 17, 2025, carries an ultimate completion date of November 7, 2025, and was awarded without a set-aside designation, demonstrating the contractor's competitive capability in...
- The Defense Logistics Agency awarded a delivery order valued at $16,154.36 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of October 17, 2025. This delivery order was awarded on a firm fixed-price basis with no set-aside designation, allowing the vendor to compete on an open basis despite its...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of September 30, 2025. The contract utilizes a firm fixed-price structure with no set-aside designation, allowing the vendor to compete on an open basis despite its small...
- The Defense Logistics Agency issued a delivery order valued at approximately $97.5K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, awarded on October 23, 2025, represents a direct purchase without set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal pharmaceutical procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 24, 2025, was awarded without a set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $33,168.26 by the Defense Logistics Agency for STELARA 90 mg/mL syringes. The award, issued on October 23, 2025, with an ultimate completion date of November 14, 2025, carries no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with an ultimate completion date of July 9, 2025. The award was made without a set-aside designation, allowing the vendor to compete directly in the federal pharmaceutical...
- SPE2DB22D9205Indefinite Delivery Contract
- SPE2DB22D9205-SPE2DB26FZF67Delivery Order
The Defense Logistics Agency issued a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract was awarded on October 21, 2025, with an ultimate completion date of November 12, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order was issued pursuant to DMS Pharmaceutical Group's Indefinite Delivery Contract under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial capability as a federal pharmaceutical supplier, with consistent performance on numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division. The company's product portfolio spans branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals, positioning it as a critical supplier within the federal military medical supply chain. The prime vendor contract, designated SPE2DR and valued at $499,999,999, extends through December 31, 2036, and authorizes the issuance of firm fixed-price delivery orders to support recurring medical supply needs across military healthcare operations globally. No subcontractors were identified in the award documentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 10/21/25 |